218 results on '"Shea, Lauren"'
Search Results
2. Peripheral T-cell lymphoma: are all patients high risk?
3. Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study
4. Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice
5. Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements
6. Evaluating real-world treatment patterns and outcomes of mantle cell lymphoma
7. Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
8. Science Plus ELA: A Natural Fit
9. Comparison of Student Success between High-Clicker and Low-Clicker Frequency in a Large-Enrollment Introductory Biology Course
10. Examining the Extremes: High and Low Performance on a Teaching Performance Assessment for Licensure
11. Classroom Practices That Support the Development of Purpose
12. A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma
13. Peripheral T-cell lymphoma: Are all patients high-risk?
14. Brentuximab Vedotin in the Treatment of Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma
15. We Are All Talking: A Whole-School Approach to Professional Development for Teachers of English Learners
16. Choosing induction chemotherapy in therapy-related acute myeloid leukemia
17. Primary Bone Marrow Diffuse Large B-cell Lymphoma Presenting as Transverse Myelitis
18. Exploring the Influences of a Partner-Based Teacher Credential Program on Candidates’ Performance Outcomes
19. 74. Genomic analyses of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common clonal origin
20. Early-Life Diet Affects Host Microbiota and Later-Life Defenses Against Parasites in Frogs
21. Postibrutinib Relapse Outcomes for Patients with Marginal Zone Lymphoma
22. Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status
23. Interim Analysis of Investigator-Initiated Phase 2 Trial of Siltuximab in Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR T-Cell Therapy
24. Postibrutinib relapse outcomes for patients with marginal zone lymphoma
25. Additional file 1 of Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study
26. Myosteatosis As a Predictor of Toxicity Among Older Adults with DLBCL Receiving CHOP-Based Regimens
27. Characteristics of Patients with Observation As Initial Treatment Strategy in Mantle Cell Lymphoma
28. Impact of Monoclonal Protein at Diagnosis on Outcomes in Patients with Marginal Zone Lymphoma: A Multicenter Cohort Study
29. Early Relapse within 24 Months after Frontline Systemic Therapy (POD24) Is Associated with Worse Survival in Patients with Marginal Zone Lymphoma: A US Multisite Study
30. Survival Disparities Among People with HIV and Diffuse Large B-Cell Lymphoma in the Era of Novel Antiretroviral Therapy
31. Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma From the United States
32. TCL-243 Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma From the United States
33. Incorporating English Language Teaching through Science for K-2 Teachers
34. Predicting Performance: A Comparison of University Supervisors' Predictions and Teacher Candidates' Scores on a Teaching Performance Assessment
35. Talking to Learn: A Mixed-Methods Study of a Professional Development Program for Teachers of English Language Learners
36. Methods and Strategies: Talk Strategies
37. T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
38. Chimeric Antigen Receptor T Cells Mediated Toxicities Are Associated with Hyponatremia
39. Methods & Strategies: Talk Strategies
40. Allogeneic Stem Cell Transplant and CD30 Directed CART Cell Therapies Are Associated with Improved Survival in Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers
41. Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers
42. Outcomes in Patients with Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers
43. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
44. Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease
45. Chapter 21 Monitoring Autophagy in Lysosomal Storage Disorders
46. 165 - Interim Analysis of Investigator-Initiated Phase 2 Trial of Siltuximab in Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR T-Cell Therapy
47. Predictive Factors and Outcomes for Ibrutinib Therapy in Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter Cohort Study
48. Subsurface automated samplers (SAS) for ocean acidification research
49. Association of trainee participation with adenoma and polyp detection rates
50. Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.